Welcome to our dedicated page for Zevia Pbc SEC filings (Ticker: ZVIA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zevia PBC filings document the public-company disclosures of a Delaware public benefit corporation focused on zero-sugar, clean-label beverages. Form 8-K reports furnish quarterly and annual earnings releases, Regulation FD investor presentations, board appointments and committee assignments, and material agreements tied to the company’s capital structure.
Proxy materials describe annual meeting matters such as director elections, auditor ratification, board structure, committee oversight and stockholder voting procedures. Other filings address the company’s Class A common stock, its wholly owned subsidiary Zevia LLC, and equity distribution arrangements used for at-the-market offering capacity.
Zevia PBC (NYSE: ZVIA) filed a Form 144 notice indicating a planned sale of up to 2,000,000 Class A common shares. The shares, to be brokered through BMO Capital Markets, have an aggregate market value of $7.28 million and represent roughly 3.0% of the 66,064,650 shares outstanding. The seller originally acquired the stock on 12/21/2020 by purchasing Series E Preferred Units that converted into common stock at the company’s IPO. No other sales were reported for the past three months, and the anticipated sale date is 06/30/2025. Form 144 filings are notices only; the transaction may not occur and the exact seller identity is not disclosed in the excerpt.
Key take-aways for investors include the size of the proposed block, the potential for incremental trading volume around the target date, and the absence of recent sales by this holder. While the filing does not signal operational changes at Zevia, it can influence supply-demand dynamics and short-term sentiment.